The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProteome Regulatory News (PRM)

Share Price Information for Proteome (PRM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.51
Bid: 3.02
Ask: 4.00
Change: 0.00 (0.00%)
Spread: 0.98 (32.45%)
Open: 3.51
High: 0.00
Low: 0.00
Prev. Close: 3.51
PRM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

30 Sep 2014 07:00

RNS Number : 9286S
Proteome Sciences PLC
30 September 2014
 



 

 

 

 

 

Proteome Sciences plc

("Proteome Sciences" or the "Company")

Appointment of new Finance Director

 

30th September, 2014 - The Board of Proteome Sciences is pleased to announce the appointment of Mr. Geoffrey Ellis as Finance Director with effect from 1st October. Mr. Geoffrey John Ellis, 53, is a chartered accountant with over 30 years' experience in a range of senior financial, operational, sales and business development roles. He spent 15 years at Walt Disney where he was Chief Financial Officer of the Network of Disney Channels in EMEA and Managing Director of Disney Chanel Scandinavia, Middle East and Emerging Markets.

In addition to a strong financial background, he brings considerable international sales, marketing and licensing expertise and a key part of his role will be managing and expanding our commercial sales and marketing in USA and Europe.

Mr. James Malthouse will remain as a director of the company until his retirement on 30th November, 2014.

Mr. Ellis was a director of Curzon ISC Limited until shortly before it was placed into voluntary liquidation in March 2011. He was also a director of Warren Close Residents Association (Esher) Limited at the time it was placed into voluntary liquidation in May 2013.

Other than disclosed above, the Company confirms that there is no further information required to be disclosed in accordance with paragraph (g) of Schedule 2 of the AIM Rules.

 

- Ends -

For further information please contact:

Proteome Sciences plc

Christopher Pearce, Executive Chairman

Dr. Ian Pike, Chief Operating Officer Tel: +44 (0)1932 865065

James Malthouse, Finance Director

 

Cenkos - Nominated Adviser

Stephen Keys/Mark Connelly /Callum Davidson Tel: +44 (0)20 7397 8900

 

finnCap - Joint Broker

Geoff Nash (Corporate Finance) Tel: +44 (0)20 7220 0500

Tony Quirke (Broking)

 

IKON Associates - Public Relations

Adrian Shaw Tel: +44 (0)1483 271291

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAVKLFLZKFFBBX
Date   Source Headline
27th Oct 201711:30 amRNSHolding(s) in Company
27th Oct 201711:30 amRNSDirector/PDMR Shareholding
23rd Oct 201712:00 pmRNSHolding(s) in Company
23rd Oct 201712:00 pmRNSDirector/PDMR Shareholding
20th Oct 201712:58 pmRNSHolding(s) in Company
18th Oct 20177:00 amRNSGCLP Accreditation and Trading Update
3rd Oct 20172:25 pmRNSBlock Admission Return
1st Sep 201712:08 pmRNSIssue of Equity
1st Aug 20177:00 amRNSDirectorate Changes
25th Jul 20177:00 amRNSInterim results for the 6 months to 30 June 2017
11th Jul 201712:00 pmRNSNotice of Results
30th Jun 201710:31 amRNSHolding(s) in Company
30th Jun 20177:00 amRNSStroke Diagnostic- Research Milestone Achieved
12th Jun 20177:00 amRNSNew Registered Address
8th Jun 20174:40 pmRNSSecond Price Monitoring Extn
8th Jun 20174:35 pmRNSPrice Monitoring Extension
15th May 20177:00 amRNSDirector/PDMR Shareholding
10th May 201710:09 amRNSDirector/PDMR Shareholding
5th May 201712:30 pmRNSDirector/PDMR Shareholding
4th May 20172:23 pmRNSHolding(s) in Company
3rd May 20177:00 amRNSDirector/PDMR Shareholding
28th Apr 20174:58 pmRNSDirector/PDMR Shareholding
28th Apr 20174:54 pmRNSHolding(s) in Company
25th Apr 20171:34 pmRNSAGM Statement and Result of AGM
11th Apr 20177:00 amRNSDirector Dealing and Total Voting Rights
4th Apr 20175:00 pmRNSHolding(s) in Company
4th Apr 20174:40 pmRNSSecond Price Monitoring Extn
4th Apr 20174:35 pmRNSPrice Monitoring Extension
4th Apr 20177:00 amRNSOption Awards
3rd Apr 20177:00 amRNSAppointment of Richard Dennis as CCO
31st Mar 20174:45 pmRNSBlock Admission Return
28th Mar 20177:00 amRNSPreliminary Results
9th Feb 20177:00 amRNSTrading Update & Notice of Results
4th Jan 20174:36 pmRNSHoldings in Company / PDMR Shareholding
3rd Jan 20171:34 pmRNSHoldings in Company / PDMR Shareholding
30th Dec 201611:42 amRNSHolding(s) in Company
19th Dec 20167:00 amRNSLaunch of new website
16th Dec 20169:28 amRNSHolding(s) in Company
29th Nov 201610:43 amRNSResult of GM and Completion of Placing
18th Nov 20169:46 amRNSHolding(s) in Company
8th Nov 201610:12 amRNSHolding(s) in Company
4th Nov 20163:52 pmRNSDirector/PDMR Shareholding & Total Voting Rights
2nd Nov 20164:35 pmRNSPrice Monitoring Extension
31st Oct 20167:00 amRNSPlacing and Subscription to raise £3.3 million
20th Oct 20164:40 pmRNSSecond Price Monitoring Extn
20th Oct 20164:35 pmRNSPrice Monitoring Extension
4th Oct 20164:35 pmRNSPrice Monitoring Extension
3rd Oct 20167:00 amRNSBlock Admission return
29th Sep 20167:00 amRNSHolding(s) in Company
22nd Sep 20167:00 amRNSPublication: Journal of Alzheimer's disease

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.